A share price of Milestone Pharmaceuticals Inc [MIST] is currently trading at $1.29, up 5.74%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MIST shares have gain 7.50% over the last week, with a monthly amount glided 45.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Milestone Pharmaceuticals Inc [NASDAQ: MIST] stock has seen the most recent analyst activity on August 22, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $9. Previously, Jefferies downgraded its rating to Hold on June 20, 2023, and dropped its price target to $4. On April 22, 2022, upgrade upgraded it’s rating to Overweight and revised its price target to $10 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $20 on March 05, 2021. Oppenheimer upgraded its rating to a Outperform but $18 remained the price target by the analyst firm on July 29, 2020. Jefferies upgraded its rating to Buy for this stock on July 24, 2020. In a note dated March 25, 2020, Jefferies downgraded an Hold rating on this stock and revised its target price from $28 to $3.
Milestone Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.63 and $2.75. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $1.29 at the most recent close of the market. An investor can expect a potential return of 675.19% based on the average MIST price forecast.
Analyzing the MIST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -1.98 and Total Capital is -1.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -9.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Milestone Pharmaceuticals Inc [NASDAQ:MIST] is 4.67. As well, the Quick Ratio is 4.67, while the Cash Ratio is 3.48.
